Fig. 6
From: Shengmai Yin formula modulates the gut microbiota of spleen-deficiency rats
a Effects of SMY on the serum content of D-xylose in spleen-deficiency model rats (\(\stackrel{-}{\mathrm{x}}\)±s, n = 8). Before medication, compared with NC, the serum levels of D-xylose in the other three groups were significantly reduced (##P < 0.01). After the last administration, SMY increased the serum level of D-xylose (Compare with MC, *P < 0.05). b Effects of SMY on the serum content of GAS in spleen-deficiency model rats (\(\stackrel{-}{\mathrm{x}}\)±s, n = 8). Compared with MC, NC and SMY had increased serum levels of GAS (**P < 0.01). c Effects of SMY on the serum content of VIP in spleen-deficiency model rats (\(\stackrel{-}{\mathrm{x}}\)±s, n = 8). Compared with MC, NC and SMY had reduced serum levels of VIP (**P < 0.01)